143 related articles for article (PubMed ID: 32631520)
1. Discovery of phenanthridine analogues as novel chemical probes disrupting the binding of DNA to ΔFosB homodimers and ΔFosB/JunD heterodimers.
Li Y; Liu Z; Aglyamova G; Chen J; Chen H; Bhandari M; White MA; Rudenko G; Zhou J
Bioorg Med Chem Lett; 2020 Aug; 30(16):127300. PubMed ID: 32631520
[TBL] [Abstract][Full Text] [Related]
2. Small molecule screening identifies regulators of the transcription factor ΔFosB.
Wang Y; Cesena TI; Ohnishi Y; Burger-Caplan R; Lam V; Kirchhoff PD; Larsen SD; Larsen MJ; Nestler EJ; Rudenko G
ACS Chem Neurosci; 2012 Jul; 3(7):546-56. PubMed ID: 22860224
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern of JunD after acute or chronic L-DOPA treatment: comparison with deltaFosB.
Valastro B; Andersson M; Lindgren HS; Cenci MA
Neuroscience; 2007 Jan; 144(1):198-207. PubMed ID: 17055656
[TBL] [Abstract][Full Text] [Related]
4. Dimerization and DNA-binding properties of the transcription factor DeltaFosB.
Jorissen HJ; Ulery PG; Henry L; Gourneni S; Nestler EJ; Rudenko G
Biochemistry; 2007 Jul; 46(28):8360-72. PubMed ID: 17580968
[TBL] [Abstract][Full Text] [Related]
5. Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease.
Berton O; Guigoni C; Li Q; Bioulac BH; Aubert I; Gross CE; Dileone RJ; Nestler EJ; Bezard E
Biol Psychiatry; 2009 Sep; 66(6):554-61. PubMed ID: 19481198
[TBL] [Abstract][Full Text] [Related]
6. Chemically targeting the redox switch in AP1 transcription factor ΔFOSB.
Kumar A; Aglyamova G; Yim YY; Bailey AO; Lynch HM; Powell RT; Nguyen ND; Rosenthal Z; Zhao WN; Li Y; Chen J; Fan S; Lee H; Russell WK; Stephan C; Robison AJ; Haggarty SJ; Nestler EJ; Zhou J; Machius M; Rudenko G
Nucleic Acids Res; 2022 Sep; 50(16):9548-9567. PubMed ID: 36039764
[TBL] [Abstract][Full Text] [Related]
7. The leucine zippers of c-fos and c-jun for progesterone receptor dimerization: A-dominance in the A/B heterodimer.
Mohamed MK; Tung L; Takimoto GS; Horwitz KB
J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):241-50. PubMed ID: 7826885
[TBL] [Abstract][Full Text] [Related]
8. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
Ramirez-Carrozzi VR; Kerppola TK
J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
[TBL] [Abstract][Full Text] [Related]
9. Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure.
Renthal W; Carle TL; Maze I; Covington HE; Truong HT; Alibhai I; Kumar A; Montgomery RL; Olson EN; Nestler EJ
J Neurosci; 2008 Jul; 28(29):7344-9. PubMed ID: 18632938
[TBL] [Abstract][Full Text] [Related]
10. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun.
Leonard DA; Rajaram N; Kerppola TK
Proc Natl Acad Sci U S A; 1997 May; 94(10):4913-8. PubMed ID: 9144164
[TBL] [Abstract][Full Text] [Related]
12. DeltaFosB: a sustained molecular switch for addiction.
Nestler EJ; Barrot M; Self DW
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11042-6. PubMed ID: 11572966
[TBL] [Abstract][Full Text] [Related]
13. Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments.
Chen J; Kelz MB; Hope BT; Nakabeppu Y; Nestler EJ
J Neurosci; 1997 Jul; 17(13):4933-41. PubMed ID: 9185531
[TBL] [Abstract][Full Text] [Related]
14. Control of the orientation of Fos-Jun binding and the transcriptional cooperativity of Fos-Jun-NFAT1 complexes.
Ramirez-Carrozzi VR; Kerppola TK
J Biol Chem; 2001 Jun; 276(24):21797-808. PubMed ID: 11259418
[TBL] [Abstract][Full Text] [Related]
15. Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements.
Cao X; Yasuda T; Uthayathas S; Watts RL; Mouradian MM; Mochizuki H; Papa SM
J Neurosci; 2010 May; 30(21):7335-43. PubMed ID: 20505100
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide variants of the TGACTCA motif modulate energetics and orientation of binding of the Jun-Fos heterodimeric transcription factor.
Seldeen KL; McDonald CB; Deegan BJ; Farooq A
Biochemistry; 2009 Mar; 48(9):1975-83. PubMed ID: 19215067
[TBL] [Abstract][Full Text] [Related]
17. DNA bending determines Fos-Jun heterodimer orientation.
Leonard DA; Kerppola TK
Nat Struct Biol; 1998 Oct; 5(10):877-81. PubMed ID: 9783746
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA.
Glover JN; Harrison SC
Nature; 1995 Jan; 373(6511):257-61. PubMed ID: 7816143
[TBL] [Abstract][Full Text] [Related]
19. JunD mutants with spontaneously acquired transforming potential have enhanced transactivating activity in combination with Fra-2.
Kameda T; Akahori A; Sonobe MH; Suzuki T; Endo T; Iba H
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9369-73. PubMed ID: 8415709
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of cooperative DNA bending and oriented heterodimer binding in the NFAT1-Fos-Jun-ARRE2 complex.
Diebold RJ; Rajaram N; Leonard DA; Kerppola TK
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):7915-20. PubMed ID: 9653115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
